San Diego Business Journal

SD HEALTHCARE

Recent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...
Tease photo

Patty Maysent Appointed CEO of UC San Diego Health

Patty Maysent has been named CEO of UC San Diego Health, effective immediately. She had held the position on an interim basis since former CEO Paul Viviano left in 2015 to run Children's Hospital Los Angeles.

Tease photo

J. Mark Dressel Named CFO at Kisco Senior Living

Carlsbad-based Kisco Senior Living has appointed J. Mark Dressel chief financial officer of its 21 senior living communities across the country.

ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2016

San Diego medical device maker ResMed Inc. reported net income of $90.5 million for the second quarter of fiscal 2016, down 1 percent from the same quarter the previous year.

Tri-City Agrees To Pay $3.3M To Settle Issue

Tri-City Medical Center, a hospital in Oceanside, has agreed to pay nearly $3.3 million in fines to resolve allegations that it violated the Stark Law and False Claims Act.

JPM: Brains, Bucks and A Whole Lot of Biotech

BIOTECH: Gathering Is Unconventional Business, Cultural Event for Sector

You’ve probably heard of CES, the yearly Consumer Electronics Show where exciting new technology — such as virtual reality headsets and self-driving cars — are announced to industry, investors and media.

AmpliPhi Biosciences Corp. Names Steve Martin CFO

AmpliPhi Biosciences Corp., a biotechnology company focused on the development and commercialization of novel bacteriophage-based antibacterial therapeutics, announced Steve R. Martin will be its new chief financial officer.

Millennium Health Announces Board of Directors

Millennium Health, the drug-testing firm that emerged from bankruptcy last month after a $256 million settlement with federal prosecutors, on Tuesday announced the creation of its new board of directors.

Organovo Holdings CFO Barry Michaels Announces Retirement

Organovo Holdings Inc., a San Diego-based 3D bioprinting firm, announced that Chief Financial Officer Barry Michaels will retire at the end of the fiscal year in March. The company will launch an immediate search for his replacement.

Tri-City Agrees to Pay $3.3M in Fines to Settle Allegations Concerning Medicare Billing Procedures

Tri-City Medical Center, a hospital in Oceanside, has agreed to pay nearly $3.3 million in fines to resolve allegations that it violated the Stark Law and False Claims Act.

Tease photo

Renova Therapeutics Names Richard McCloskey Executive VP of Clinical Development

Renova Therapeutics, a San Diego-based gene therapy company, announced Thursday that it has recruited Dr. Richard 'Mac' McCloskey to be executive vice president of clinical development.

Tease photo

Sharp Grossmont Completes $41M Renovation on East Tower

Sharp Grossmont Hospital’s East Tower is officially open for business following the completion of a three-year, $41 million renovation.

Tease photo

Biz Taps a Rich Vein: Hangover Sufferers

SERVICE: I.V. Society’s Product Is Rehydration

It’s not uncommon for those who enjoy San Diego’s craft beer and beach nightlife to drink too much. Visiting conventioneers, vacationers and wedding parties are particularly prone to excess (let’s call it the “carpe diem effect”).

Organovo Subsidiary Samsara Launches Commercial Operations

San Diego’s 3D bioprinting firm Organovo Holdings, Inc. announced Wednesday that its subsidiary Samsara Sciences Inc. has officially launched commercial operations.

Apricus Biosciences to Raise $10 Million From Stocks, Warrants Offering

San Diego-based Apricus Biosciences Inc. announced that it has entered into agreements to raise $10 million in a registered direct offering of stocks and warrants.

Illumina Forms Company to Develop Blood Test for Cancer

San Diego-based Illumina, the world’s largest maker of DNA sequencing machines, said Sunday that it was forming a company to develop a blood test that can detect any kind of cancer at an early stage.